Read + Share
Amedeo Smart
Independent Medical Education
Brun MK, Goll GL, Jorgensen KK, Sexton J, et al. Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial. J Intern Med 2022;292:477-491.PMID: 35411981
Email
LinkedIn
Facebook
Twitter
Privacy Policy